Siemens CEO Joe Kaeser tells a German newspaper that the conglomerate will hold on to its healthcare business, squelching speculation about a Siemens Healthcare spinout.
Siemens resigns itself to another year of flat sales and deals its hearing aids business to private equity firm EQT for $2.7 billion.
(Reuters) - Siemens (NYSE:SI) resigned itself to another year of flat sales today after reporting that 1-off charges hit profits again in the 4th quarter, this time for wind turbines.
Siemens is in advanced talks to sell its hearing-aids business to private equity shop EQT, unnamed sources tell Reuters.
Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Inside the Medtronic-Covidien deal: Contrasting styles brought the companies together; Medtronic and Covidien prepare 1st Integration Summit; FTC approves Cerner's $1.3B Siemens health IT buy; Alere unveils $3.82B privatization plan; Medtronic, Covidien slide on new U.S. inversion rules
Cerner gets federal approval for its $1.3 billion acquisition of Siemens' health information technology business.
Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Johnson & Johnson eyes acquisitions in cardiovascular, elsewhere; Abbott CEO defends inversions amid corporate exodus furor; Medtronic fights tax dodging rhetoric in Covidien merger; Could Medtronic-Covidien deal get caught in anti-inversion legislation?; Siemens sells clinical microbiology biz to Beckman Coulter
Beckman Coulter picks up Siemens Healthcare Diagnostics' clinical microbiology business in a closed-doors deal.